11-Hydroxysugiol

Cat. No.: HY-107218: FAQs
Data Sheet Handling Instructions

Molarity Calculator

11-Hydroxysugiol regulates the SUMOylation of intracellular receptors by modulating RARα and vitamin D₃ receptor (VDR).

For research use only. We do not sell to patients.

11-Hydroxysugiol Chemical Structure

CAS No. : 88664-08-8

Size		Stock
MOQ		Minimum order quantity
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All RAR/RXR Isoform Specific Products:

View All Isoforms

RXRα RXRβ RXRγ

Biological Activity
Purity & Documentation
References
Customer Review

Description

11-Hydroxysugiol regulates the SUMOylation of intracellular receptors by modulating RARα and vitamin D₃ receptor (VDR)^[1].

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	> 10 μM Compound: 16	Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33978415]
A549	GI₅₀	35.04 μM Compound: 12	Cytotoxicity against human A549 cells assessed as growth inhibition by WST-8 assay Cytotoxicity against human A549 cells assessed as growth inhibition by WST-8 assay	[PMID: 24210499]
BEAS-2B	IC₅₀	> 10 μM Compound: 16	Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33978415]
BXPC-3	GI₅₀	45.01 μM Compound: 12	Cytotoxicity against human BxPC3 cells assessed as growth inhibition by WST-8 assay Cytotoxicity against human BxPC3 cells assessed as growth inhibition by WST-8 assay	[PMID: 24210499]
HeLa	IC₅₀	39.6 μM Compound: 8	Cytotoxicity against human HeLa cells in lag phase of growth after 48 hrs Cytotoxicity against human HeLa cells in lag phase of growth after 48 hrs	[PMID: 24709561]
HeLa	IC₅₀	41.1 μM Compound: 8	Cytotoxicity against human HeLa cells in log phase of growth after 48 hrs Cytotoxicity against human HeLa cells in log phase of growth after 48 hrs	[PMID: 24709561]
HEp-2	IC₅₀	46.2 μM Compound: 8	Cytotoxicity against human Hep2 cells in log phase of growth after 48 hrs Cytotoxicity against human Hep2 cells in log phase of growth after 48 hrs	[PMID: 24709561]
HEp-2	IC₅₀	49.4 μM Compound: 8	Cytotoxicity against human Hep2 cells in lag phase of growth after 48 hrs Cytotoxicity against human Hep2 cells in lag phase of growth after 48 hrs	[PMID: 24709561]
HL-60	IC₅₀	> 10 μM Compound: 16	Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33978415]
HL-60	GI₅₀	35.26 μM Compound: 12	Cytotoxicity against human HL60 cells assessed as growth inhibition by WST-8 assay Cytotoxicity against human HL60 cells assessed as growth inhibition by WST-8 assay	[PMID: 24210499]
MCF7	IC₅₀	> 10 μM Compound: 16	Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33978415]
MRC5	GI₅₀	40.19 μM Compound: 12	Cytotoxicity against human MRC5 cells assessed as growth inhibition by WST-8 assay Cytotoxicity against human MRC5 cells assessed as growth inhibition by WST-8 assay	[PMID: 24210499]
PANC-1	GI₅₀	43.14 μM Compound: 12	Cytotoxicity against human PANC1 cells assessed as growth inhibition by WST-8 assay Cytotoxicity against human PANC1 cells assessed as growth inhibition by WST-8 assay	[PMID: 24210499]
PC-3	GI₅₀	41.03 μM Compound: 12	Cytotoxicity against human PC3 cells assessed as growth inhibition by WST-8 assay Cytotoxicity against human PC3 cells assessed as growth inhibition by WST-8 assay	[PMID: 24210499]
RAW264.7	IC₅₀	15.5 μM Compound: 38	Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay	[PMID: 29924604]
SMMC-7721	IC₅₀	> 10 μM Compound: 16	Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33978415]
SW480	IC₅₀	> 10 μM Compound: 16	Cytotoxicity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTS assay Cytotoxicity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTS assay	[PMID: 33978415]
Vero	IC₅₀	47.5 μM Compound: 8	Cytotoxicity against African green monkey Vero cells in lag phase of growth after 48 hrs Cytotoxicity against African green monkey Vero cells in lag phase of growth after 48 hrs	[PMID: 24709561]
Vero	IC₅₀	47.5 μM Compound: 8	Cytotoxicity against African green monkey Vero cells in log phase of growth after 48 hrs Cytotoxicity against African green monkey Vero cells in log phase of growth after 48 hrs	[PMID: 24709561]

Molecular Weight

316.43

Formula

C₂₀H₂₈O₃

CAS No.

88664-08-8

SMILES

C[C@@]12C3=C(O)C(O)=C(C(C)C)C=C3C(C[C@@]1([H])C(C)(CCC2)C)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Handling Instructions (2659 KB)

References

[1]. Meenaxi M. Maste, et al. Screening of Plectranthus amboinicus against COVID-19-in silico approach. J App Pharm Sci. 2020; 10(12): 90-97.